Cellbion

셀비온 · 308430

Health Care Pharmaceuticals · KOSDAQ

Small-cap

Market cap US$181.4M (₩250.4B)

Overview

Company summary coming soon.

Source: DART · FY ending Dec · latest FY2025

Revenue · FY2025

US$1.4M

▼ −15.0% YoY

Operating profit · FY2025

−US$6M

Loss widened

Net income · FY2025

−US$5.5M

Loss widened

Revenue, operating profit and net income by fiscal year (USD; KRW in parentheses).
Metric	FY2024	FY2025
Revenue	US$1.7M(₩2.3B)	US$1.4M(₩1.9B)
Operating profit	−US$5.2M(−₩7.1B)	−US$6M(−₩8.2B)
Net income	−US$5.3M(−₩7.3B)	−US$5.5M(−₩7.6B)

Revenue

Operating profit

Net income

ROE

-33.2%

Debt/Eq

54.5%

Op. margin

-423.9%

Net margin

-389.4%

Rev. YoY

▼ −15.0%

Interactive price history isn't here yet. Would you use it?